<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Eckl-Dorna J</submitter><funding>Austrian Science Fund FWF</funding><pagination>1222-9</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4949646</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>70(10)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The adaptive immunity underlying allergy comprises two components, the allergen-specific antibody (i.e. IgE, IgG) and the T-cell response. These two components are responsible for different disease manifestations and can be targeted by different therapeutic approaches. Here, we investigated the association of allergen-specific antibody and T- as well as B-cell responses in pollen-allergic patients using recombinant (r) major birch pollen allergen rBet v 1 and major timothy grass pollen allergen rPhl p 5 as defined antigens.&lt;h4>Methods&lt;/h4>Allergen-specific IgE and IgG antibody responses were determined by ELISA, and allergen-specific T- and B-cell responses were measured in peripheral blood mononuclear cells using a carboxyfluorescein-diacetate-succinimidylester (CFSE) d</pubmed_abstract><journal>Allergy</journal><pubmed_title>Poor association of allergen-specific antibody, T- and B-cell responses revealed with recombinant allergens and a CFSE dilution-based assay.</pubmed_title><pmcid>PMC4949646</pmcid><funding_grant_id>F4613</funding_grant_id><funding_grant_id>F4605</funding_grant_id><funding_grant_id>F 4605</funding_grant_id><pubmed_authors>Eckl-Dorna J</pubmed_authors><pubmed_authors>Valenta R</pubmed_authors><pubmed_authors>Campana R</pubmed_authors><pubmed_authors>Niederberger V</pubmed_authors></additional><is_claimable>false</is_claimable><name>Poor association of allergen-specific antibody, T- and B-cell responses revealed with recombinant allergens and a CFSE dilution-based assay.</name><description>&lt;h4>Background&lt;/h4>The adaptive immunity underlying allergy comprises two components, the allergen-specific antibody (i.e. IgE, IgG) and the T-cell response. These two components are responsible for different disease manifestations and can be targeted by different therapeutic approaches. Here, we investigated the association of allergen-specific antibody and T- as well as B-cell responses in pollen-allergic patients using recombinant (r) major birch pollen allergen rBet v 1 and major timothy grass pollen allergen rPhl p 5 as defined antigens.&lt;h4>Methods&lt;/h4>Allergen-specific IgE and IgG antibody responses were determined by ELISA, and allergen-specific T- and B-cell responses were measured in peripheral blood mononuclear cells using a carboxyfluorescein-diacetate-succinimidylester (CFSE) d</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Oct</publication><modification>2025-04-04T21:52:13.436Z</modification><creation>2019-03-27T02:18:42Z</creation></dates><accession>S-EPMC4949646</accession><cross_references><pubmed>26043182</pubmed><doi>10.1111/all.12661</doi></cross_references></HashMap>